Y-mAbs Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Y-mAbs Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q2 2024.
  • Y-mAbs Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 44.6M shares, a 2.17% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 44.6M +947K +2.17% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 43.9M +175K +0.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 43.7M +2K +0.01% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 43.6M -46.5K -0.11% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 43.6M -99.8K -0.23% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 43.7M -40.4K -0.09% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 43.7M -24.6K -0.06% Dec 31, 2022 10-K 2024-02-29
Q3 2022 43.7M +24.2K +0.06% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 43.7M +143K +0.33% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 43.7M +170K +0.39% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 43.7M +3.01M +7.39% Dec 31, 2021 10-K 2023-03-30
Q3 2021 43.6M +3.17M +7.84% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 43.6M +3.56M +8.9% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 43.5M +3.79M +9.54% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 40.7M +960K +2.42% Dec 31, 2020 10-K 2022-03-01
Q3 2020 40.5M +5.88M +17% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 40M +5.82M +17% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 39.8M +5.56M +16.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 39.7M +5.53M +16.2% Dec 31, 2019 10-K 2022-03-01
Q3 2019 34.6M +400K +1.17% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 34.2M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 34.2M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 34.2M +7.44M +27.8% Dec 31, 2018 10-K 2020-03-12
Q3 2018 34.2M Sep 30, 2018 10-Q 2018-11-13
Q4 2017 26.7M Dec 31, 2017 10-K 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.